Chen DY, Lee Y, Van Tine BA, Searleman AC, Westergard TD, Liu H, Tu HC, Takeda S, Dong Y, Piwnica-Worms DR, Oh KJ, Korsmeyer SJ, Hermone A, Gussio R, Shoemaker RH, Cheng EH, Hsieh JJ. 2012 A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth. Cancer Research, 72(3), 736-746.

Hakimi A, Chen Y, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, and Hsieh JJ. Clinical and Pathologic Impact of Select Chromatin Modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma. European Urology, 2012, 63, 848-854.

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Vanharanta S, Shu W, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massagué J. Nat Med. 2012. 19, 50-56.

PUMA and BIM Are Required for Oncogene Inactivation-Induced Apoptosis. Bean GR, Ganesan YT, Dong Y, Takeda S, Liu H, Chan PM, Huang Y, Chodosh LA, Zambetti GP, Hsieh JJ, Cheng EH. Sci Signal. 2013 Mar 26;6(268):ra20. doi: 10.1126/scisignal.2003483.

Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: a Report by MSKCC and the KIRC TCGA Research Network.Hakimi AA, Ostrovnaya I, Reva B, Schultz N, Chen Y, Gonen M, Liu H, Takeda S, Voss MH, Tickoo SK, Reuter VE, Russo P, Cheng EH, Sander C, Motzer RJ, and Hsieh JJ for The ccRCC Cancer Genome Atlas (KIRC TCGA) Research Network investigators. Clin Can Res. 2013, 19, 3259-67.

HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma. TakedaS, Liu H, Sasagawa S, Trainor PA, Cheng EH, Hsieh JJ. J Clin Invest, 2013, 123, 3154-3165.

Integrative Analysis of Genomic and Molecular Alterations in Clear Cell Renal Cell Carcinoma, The Cancer Genome Atlas Research Network* (Hsieh JJ), Nature, 2013, 499, 43-49.

Clear Picture of Renal Cell Carcinoma. Hakimi AA, Pham CG, Hsieh JJ. Nature Genetics, 2013, 45, 849-850.

Hsieh J.J.-D., Hayward, S.D. 1995. Masking of the CBF1/RBPJk Transciptional Repression Domain by Epstein-Barr Virus EBNA2. Science. 268:560-563.

Hsieh J.J.-D., Henkel T., Salmon P., Robey E, Peterson M.G., Hayward S.D. 1996. Truncated Mammalian Notch1 Activates CBF1/RBPJk Repressed Genes by a Mechanism Resembling that of Epstein-Barr Virus EBNA2. Mol. Cell. Biol. 16:952-959.

Hsieh J.J.-D., Nofziger D.E., Weinmaster G., Hayward S.D. 1997. Epstein-Barr Virus Immortalization: Notch2 Interacts with CBF1 and Blocks Differentiation. J. Virol. 71:1938-1945.

Hsieh J.J.-D., Zhou S., Chen L., Hayward S.D. 1999. CIR, A Corepressor Linking the DNA Binding Factor CBF1 to the Histone Deacetylase Complex. Proc. Natl. Acad. Sci. USA 9:23-28.

Hsieh J.J.-D., Ernst P., Erdjment-Bromage H., Tempst P., Korsmeyer S.J. 2003. Proteolytic Cleavage of MLL Generates a Complex of N-terminal and C-terminal Fragments that Confers Protein Stability and Subnuclear Localization. Mol. Cell. Biol. 23:186-194.

Hsieh J.J.-D., Cheng E.H., Korsmeyer S.J. 2003. Taspase1: a Threonine Aspartase Required for MLL Cleavage and Proper HOX Gene Expression. Cell 115, 293-303.

Zhou H., Spicuglia S., Hsieh J.J.-D., Mitsiou D.J., Hoiby T., Veenstra G.J., Korsmeyer S.J., Stunnenberg H.G. 2006. Uncleaved TFIIA is a Substrate for Taspase 1 and Active in Transcription. Mol. Cell. Biol. 26(7):2728-35.

Takeda S., Chen D.Y., Westergard T.D., Fisher J.K., Rubens J.A., Sasagawa S., Kan J.T., Korsmeyer S.J., Cheng E.H.-Y., Hsieh J.J.-D. 2006. Proteolysis of MLL Family Proteins is Essential for Taspase1-Orchestrated Cell Cycle Progression. Genes & Development, 20, 2397-2409.

Capotosti F., Hsieh J.J.-D., Herr W. 2007. Species Selectivity of Mixed Lineage Leukemia/Trithorax and HCF proteolytic Maturation Pathways. Mol. Cell. Biol. 27(20), 7063-72.

Liu H., Cheng E.H.-Y., Hsieh J.J.-D. 2007. Bimodal Degradation of MLL by SCFSkp2 and APCCdc20 Assures Cell Cycle Execution: a Critical Regulatory Circuit Lost in Leukemogenic MLL-Fusions. Genes & Development, 21(19), 2385-98.

Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y., Hsieh J.J.-D., Bauer U. 2007. PRMT6-Mediated Methylation of R2 in Histone H3 Antagonizes H3 K4 Trimethylation. Genes & Development, 21(24), 3369-3380.

Lee J.T., Chen D.Y., Yang Z., Ramos A.D., Hsieh J.J.-D., Bogyo M. 2009. Design, syntheses, and evaluation of Taspase1 inhibitors. Bioorg Med Chem Lett, 19(17), 5086-90.

Chen D.Y., Liu H., Takeda S., Tu H., Sasagawa S, Van Tine B., Lu D., Cheng E.H.-Y., Hsieh J.J.-D. 2010. Taspase1 Functions as a Non-oncogene Addiction Protease that Coordinates Cancer Cell Proliferation and Apoptosis. Cancer Research, 70(13), 5358-67.

Liu H., Takeda S., Kumar R., Westergard T.D., Brown E.J., Pandita T., Cheng E.H.-Y., Hsieh J.J.-D. 2010. Phosphorylation of MLL by ATR is Required for Execution of Mammalian S Phase Checkpoint. Nature. 467(7313):343-6.

Ren D., Tu H., Kim H., Wang G.X., Bean G.R., Takeuchi O., Jeffers J.R., Zambetti G.P., Hsieh J.J.-D., Cheng, E.H.-Y. BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program. Science 2010; 330:1390-3.